• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tamoxifen-induced fatty liver in patients with breast cancer.

作者信息

Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S

出版信息

Lancet. 1998 Mar 7;351(9104):725. doi: 10.1016/S0140-6736(05)78493-2.

DOI:10.1016/S0140-6736(05)78493-2
PMID:9504521
Abstract
摘要

相似文献

1
Tamoxifen-induced fatty liver in patients with breast cancer.他莫昔芬诱发的乳腺癌患者脂肪肝
Lancet. 1998 Mar 7;351(9104):725. doi: 10.1016/S0140-6736(05)78493-2.
2
Tamoxifen-induced transient multifocal hepatic fatty infiltration.他莫昔芬诱导的短暂性多灶性肝脂肪浸润。
Am J Gastroenterol. 2000 Jan;95(1):277-9. doi: 10.1111/j.1572-0241.2000.01708.x.
3
Cirrhosis with steatohepatitis after adjuvant tamoxifen.辅助性他莫昔芬治疗后出现脂肪性肝炎的肝硬化
Lancet. 1999 Jan 2;353(9146):36-7. doi: 10.1016/S0140-6736(05)74872-8.
4
Tamoxifen-induced fatty liver disease in a Caucasian patient.他莫昔芬诱发一名白种人患者患脂肪肝疾病。
Breast Cancer Res Treat. 2018 Aug;171(1):243-244. doi: 10.1007/s10549-018-4817-8. Epub 2018 May 7.
5
Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.非诺贝特用于他莫昔芬诱导的非酒精性脂肪性肝炎
Lancet. 1999 May 22;353(9166):1802. doi: 10.1016/S0140-6736(05)75907-9.
6
CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients.细胞色素P450 17α羟化酶多态性作为乳腺癌患者他莫昔芬诱导肝脂肪变性的危险因素。
Oncol Rep. 2005 Mar;13(3):485-9.
7
Tamoxifen in early breast cancer.早期乳腺癌中的他莫昔芬
Lancet. 1998 Aug 1;352(9125):404. doi: 10.1016/S0140-6736(05)60502-8.
8
Tamoxifen-induced cirrhotic process.他莫昔芬诱导的肝硬化过程。
Breast J. 2001 Nov-Dec;7(6):442-3. doi: 10.1046/j.1524-4741.2001.07613.x.
9
Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.托瑞米芬在接受保乳治疗的乳腺癌患者中诱发脂肪肝和非酒精性脂肪性肝炎。
Int J Oncol. 2000 Dec;17(6):1119-23. doi: 10.3892/ijo.17.6.1119.
10
Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver.他莫昔芬诱导脂肪肝的乳腺癌患者低密度脂蛋白颗粒的大小和氧化敏感性
J Clin Endocrinol Metab. 2002 Aug;87(8):3676-81. doi: 10.1210/jcem.87.8.8709.

引用本文的文献

1
Blockade of the estrogen receptor alpha-pregnane X receptor axis protects ovariectomized mice against ethanol-induced hepatotoxicity.雌激素受体α-孕烷X受体轴的阻断可保护去卵巢小鼠免受乙醇诱导的肝毒性。
J Biol Chem. 2025 May 15;301(6):110238. doi: 10.1016/j.jbc.2025.110238.
2
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?性激素：治疗女性代谢功能障碍相关脂肪性肝病的潜在靶点？
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102459. doi: 10.1016/j.jceh.2024.102459. Epub 2024 Nov 19.
3
Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy.
乳腺癌幸存者中的糖尿病：内分泌治疗的代谢影响。
Nat Rev Endocrinol. 2024 Jan;20(1):16-26. doi: 10.1038/s41574-023-00899-0. Epub 2023 Oct 2.
4
Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research-Brief Report.他莫昔芬的混杂效应：在动脉粥样硬化研究中使用他莫昔芬诱导型小鼠模型的警示和实用注意事项-简报。
Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2223-2230. doi: 10.1161/ATVBAHA.123.319922. Epub 2023 Sep 14.
5
Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice.短期他莫昔芬给药通过 JNK/MAPK 改善小鼠肝脂肪变性和葡萄糖不耐受。
Signal Transduct Target Ther. 2023 Mar 3;8(1):94. doi: 10.1038/s41392-022-01299-y.
6
Pseudocirrhosis in Breast Cancer - Experience From an Academic Cancer Center.乳腺癌中的假肝硬化——来自一家学术性癌症中心的经验
Front Oncol. 2021 Jul 2;11:679163. doi: 10.3389/fonc.2021.679163. eCollection 2021.
7
Extrapolating from acute to chronic toxicity in vitro.从体外急性毒性推断慢性毒性。
Toxicol In Vitro. 2021 Oct;76:105206. doi: 10.1016/j.tiv.2021.105206. Epub 2021 Jun 26.
8
Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.雌激素相关受体α依赖性肝 VLDL 分泌功能障碍导致 NAFLD/NASH 发展的性别差异。
Theranostics. 2020 Aug 29;10(24):10874-10891. doi: 10.7150/thno.47037. eCollection 2020.
9
NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.绝经后妇女的非酒精性脂肪性肝病和非酒精性脂肪性肝炎：诊断和治疗的意义。
Endocrinology. 2020 Oct 1;161(10). doi: 10.1210/endocr/bqaa134.
10
Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway.他莫昔芬通过MAPK8/FoxO途径诱发乳腺癌患者的脂肪肝疾病。
Clin Transl Med. 2020 Jan;10(1):137-150. doi: 10.1002/ctm2.5. Epub 2020 Apr 23.